Immunology and rheumatology
56 drugs
Antiproliferative immunosuppressants
- About this sectionDrugs that stop immune cells from multiplying by starving them of the building blocks of DNA. Used in…
- AzathioprinePurine synthesis, through thioguanine nucleotides
- Mycophenolate mofetilInosine monophosphate dehydrogenase (IMPDH)
Calcineurin inhibitors
- About this sectionTransplant medicines that stop T cells from switching on by blocking calcineurin. Their blood levels are…
- CiclosporinCalcineurin, through cyclophilin A
- TacrolimusCalcineurin, through FKBP12
Complement inhibitors
- About this sectionAntibodies and peptides that block a step of the complement cascade, used in PNH, atypical HUS and some…
- EculizumabComplement component C5 (plasma protein)
- PegcetacoplanComplement component C3 (plasma protein)
- RavulizumabComplement component C5 (plasma protein)
Conventional disease-modifying antirheumatic drugs (DMARDs)
- About this sectionSlow-acting medicines that calm the immune attack in rheumatoid arthritis and lupus and protect the joints…
- HydroxychloroquineAcidic intracellular vesicles (lysosomes; the malaria parasite's food vacuole)
- LeflunomideDihydroorotate dehydrogenase (DHODH)
Hereditary angioedema agents
- About this sectionDrugs that stop or prevent bradykinin swelling in hereditary angioedema: C1 inhibitor, a bradykinin receptor…
- BerotralstatPlasma kallikrein (serine protease)
- C1 esterase inhibitorProteases it inhibits: plasma kallikrein, activated factor XII and complement C1r/C1s
- IcatibantBradykinin B2 receptor (G-protein–coupled)
- LanadelumabPlasma kallikrein
Immunoglobulins and antitoxins
- About this sectionReady-made antibodies, human or equine, that give immediate but temporary protection against a toxin, a…
- Anti-D immunoglobulin (Rho(D))RhD antigen on fetal red cells
- Diphtheria antitoxin (equine)Circulating diphtheria toxin
- Human tetanus immunoglobulinFree tetanospasmin (tetanus toxin)
- NirsevimabFusion (F) protein of respiratory syncytial virus
- Normal human immunoglobulin (IVIG)Broad repertoire of antigens and Fc receptors
- Rabies immunoglobulinRabies virus glycoprotein G
Interferons
- About this sectionProtein medicines copied from the body's antiviral signals. Once central for hepatitis, they are now used…
- Interferon alfaType I interferon receptor (IFNAR1/IFNAR2)
- Interferon betaType I interferon receptor (IFNAR1/IFNAR2)
- Interferon gammaInterferon gamma receptor (IFNGR1/IFNGR2)
Interleukin inhibitors
- About this sectionBiologics that block one interleukin (IL-1, IL-6, IL-12/23 or IL-17) or its receptor, chosen according to…
- AnakinraInterleukin-1 receptor type 1 (IL-1R1)
- CanakinumabInterleukin-1β (IL-1β)
- GuselkumabInterleukin-23, p19 subunit (IL-23p19)
- IxekizumabInterleukin-17A (IL-17A)
- RisankizumabInterleukin-23, p19 subunit (IL-23p19)
- SarilumabInterleukin-6 receptor (IL-6R)
- SecukinumabInterleukin-17A (IL-17A)
- TocilizumabInterleukin-6 receptor (IL-6R), soluble and membrane-bound
- Ustekinumabp40 subunit shared by interleukin-12 and interleukin-23
JAK inhibitors
- About this sectionSmall oral molecules that block Janus kinases inside cells, cutting the signal of many cytokines at once…
- AbrocitinibJanus kinase 1 (JAK1)
- BaricitinibJanus kinases JAK1 and JAK2
- DeucravacitinibTyrosine kinase 2 (TYK2), regulatory pseudokinase (JH2) domain
- RuxolitinibJanus kinases JAK1 and JAK2
- TofacitinibJanus kinases, mainly JAK1 and JAK3
- UpadacitinibJanus kinase 1 (JAK1)
mTOR inhibitors
- About this sectionDrugs that block mTOR, a master switch of cell growth: used to prevent transplant rejection and to treat…
- EverolimusmTOR (mechanistic target of rapamycin), through FKBP12
- SirolimusmTOR (mechanistic target of rapamycin), through FKBP12
Other antigout agents
- About this sectionMedicines for gout that do not block xanthine oxidase: colchicine for flares, probenecid to pass more urate…
- Colchicineβ-tubulin (microtubules)
- PegloticaseUric acid (the drug is the enzyme uricase)
- ProbenecidUrate transporter URAT1 (and organic anion transporters OAT1 and OAT3)
Other immunomodulating biologics
- About this sectionBiologics that act on lymphocytes rather than on a cytokine: they block T-cell co-stimulation, the IL-2…
- AbataceptCD80 and CD86 (B7-1 and B7-2) on antigen-presenting cells
- AnifrolumabType I interferon receptor subunit 1 (IFNAR1)
- Anti-thymocyte globulinMany T-lymphocyte surface proteins (CD2, CD3, CD4, CD8, CD25, HLA molecules and others)
- BasiliximabIL-2 receptor alpha chain (CD25)
- BelataceptCD80 and CD86 (B7-1 and B7-2) on antigen-presenting cells
- BelimumabB-lymphocyte stimulator (BLyS, also called BAFF)
- Vedolizumabα4β7 integrin on gut-homing lymphocytes
TNF inhibitors
- About this sectionBiologic medicines that block TNF-α, a key cytokine of inflammation. Used in rheumatoid arthritis…
- AdalimumabTumour necrosis factor alpha (TNF-α), soluble and membrane-bound
- Certolizumab pegolTumour necrosis factor alpha (TNF-α)
- EtanerceptTumour necrosis factor alpha (TNF-α)
- GolimumabTumour necrosis factor alpha (TNF-α)
- InfliximabTumour necrosis factor alpha (TNF-α)
Xanthine oxidase inhibitors
- About this sectionDrugs that cut uric acid production by blocking the last enzyme of purine breakdown. The long-term treatment…
- AllopurinolXanthine oxidase
- FebuxostatXanthine oxidase
A to Z
Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.
Representative model, for educational purposes only.
